Key result
Everolimus stabilizes supraventricular tachycardia in a neonate with TSC1-associated cardiac rhabdomyoma through 6 months.
Why the study?
Fetal cardiac rhabdomyomas are strongly associated with tuberous sclerosis complex, and TSC1 mutations are less frequently reported than TSC2, making prenatal molecular confirmation clinically valuable.
Case Report (n=1)
This case demonstrates the utility of prenatal diagnosis, genetic confirmation of familial TSC1 mutation, and postnatal everolimus therapy for managing supraventricular tachycardia in a neonate with multiple cardiac rhabdomyomas.
Answers are grounded in this paper and cite their sources.
May support everolimus for SVT in neonatal TSC rhabdomyomas; leaves open generalizability pending prospective data.
Fetal cardiac rhabdomyomas are the most common primary cardiac tumors and are strongly associated with tuberous sclerosis complex (TSC). Mutations involving the TSC1 gene are less frequently reported than TSC2 , making prenatal molecular confirmation clinically valuable. We report a case of multiple fetal cardiac rhabdomyomas detected antenatally in a 29-year-old primigravida with multiple soft markers on anomaly scan but negative aneuploidy testing. At 30 weeks’ gestation, fetal echocardiography demonstrated multiple intracardiac masses involving both ventricles and the right atrial appendage. Whole-exome sequencing identified a heterozygous nonsense pathogenic variant c.1525C>T (p.Arg509Ter) in the TSC1 gene, with targeted parental testing confirming autosomal dominant familial transmission. Postnatally, the neonate developed supraventricular tachycardia likely representing progression of prenatal atrial ectopy and was treated with everolimus, resulting in rhythm stabilization. At 6-month follow-up, the infant remains clinically stable. This case highlights the importance of prenatal diagnosis, genetic confirmation, recurrence-risk counseling, and multidisciplinary management in TSC-associated cardiac rhabdomyomas.
No takes yet. Share an insight, caveat, or question.
Lavanya et al. (2026) conducted a case report in Multiple fetal cardiac rhabdomyomas with familial TSC1 mutation and neonatal supraventricular tachycardia (n=1). Everolimus was evaluated on Rhythm stabilization and clinical stability at 6-month follow-up. Everolimus stabilized supraventricular tachycardia in a neonate with prenatally diagnosed TSC1-associated cardiac rhabdomyomas, maintaining clinical stability at 6-month follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: